Tag: Adoptive cell therapy

A review in Discover Oncology examines how engineered materials can address manufacturing, delivery, and safety bottlenecks across cellular immunotherapy.

A comprehensive scientific review details how natural polysaccharide nanocarriers remodel the immunosuppressive liver tumor microenvironment by repolarizing macrophages, activating innate ...

A scientific review highlights how precision targeting of the ITGB2 and ICAM-1 axis could overcome historical toxicity to improve cancer ...

A new review synthesizes how tissue-resident memory T cells act as frontline immune sentinels in tumors and could guide biomarker ...

A 2026 review finds that TCR-engineered T cells have entered early clinical testing for hepatocellular carcinoma, but safety, antigen heterogeneity ...

UCLA researchers used a genome-wide CRISPR screen to identify the Cullin-5 RING E3 ligase complex as a key driver of ...

A new review in Molecular Biology Reports surveys how engineered CAR-T, TCR, TIL, NK and NKT cell therapies, gene editing, ...

WEHI researchers have discovered that gamma delta T cells can recognise and kill small cell lung cancer, and that two ...

Researchers have developed an optimized tumor-infiltrating lymphocyte manufacturing protocol that shows preclinical efficacy against NF1- and schwannomatosis-related nerve sheath tumors, ...

Researchers report that adding interleukin-18 to cultures of scarce human Vδ1 T cells boosts their expansion, survival and antitumor performance ...